32.15
0.00%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Carilex Medical
Its shares trade on Taipei Exchange under the ticker 7726.TWO. It has been listed since 27 February 2024. In the fiscal year to 31 December 2025, it reported revenue of TWD 338.6m and a net loss of TWD 29.0m. At that date it held total assets of TWD 534.0m and shareholders' equity of TWD 290.9m.
Carilex Medical Inc is a TW-based company operating in industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2024-02-27. Carilex Medical Inc is a Taiwan-based company mainly engaged in the design, manufacturing and sales of medical equipments. The firm's main products include therapeautic support surface and negative pressure wound therapy machine, which are used in medical wards, acute wards, nursing institutions and home care. The therapeautic support surface is designed for patients who need to stay in bed for long periods of time or who are unable to turn over on their own. The negative pressure wound therapy machine can be convenient and effective for wound supportive therapy. The product includes antibacterial sponge in contact with the wound, waterproof film on the outer layer, and the machine for creating negative pressure. The firm mainly operates in the European, American, New Zealand and Australian markets, as well as the Taiwan markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 27 Feb 2024
- Website
- carilexmedical.com ↗
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Carilex Medical Inc designs and manufactures therapeutic support surfaces for bedridden patients in Europe and America.
- Carilex Medical Inc's negative pressure wound therapy machines are used in medical wards and home care settings across multiple markets.
- Carilex Medical Inc's products include antibacterial sponges and waterproof films for effective wound therapy.
Weaknesses
- Carilex Medical Inc's main markets are limited to Europe, America, New Zealand, Australia, and Taiwan.
- Carilex Medical Inc's products are primarily used in medical wards and home care settings.
- Carilex Medical Inc's IPO was on 27 February 2024, which may limit market presence.
Opportunities
- Carilex Medical Inc can expand into new markets beyond Europe, America, New Zealand, Australia, and Taiwan.
- Carilex Medical Inc can develop new products for the growing healthcare sector.
- Carilex Medical Inc can increase sales in the European and American markets.
Threats
- Carilex Medical Inc faces competition from other medical equipment manufacturers in Europe and America.
- Carilex Medical Inc's products are dependent on the healthcare sector's demand.
- Carilex Medical Inc's operations are concentrated in Taiwan, which could be affected by regional economic changes.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.